Article
Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
Atherosclerosis - 1 Mar 2001
Boemi M, Leviev I, Sirolla C, Pieri C, Marra M, James R W
Abstract excerpt
Paraoxonase is a serum enzyme with an anti-oxidant function, protecting low density lipoproteins (LDL) from oxidative modifications. Diabetic patients are suggested to be at greater risk of oxidative stress, which may contribute to the significantly higher incidence of vascular disease in this population. Less efficient protection mechanisms may be one feature of the greater susceptibility to oxidation in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
